Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
e.l.f. Beauty
ELF
|
+$175M |
| 2 |
Repligen
RGEN
|
+$122M |
| 3 |
CFLT
Confluent
CFLT
|
+$100M |
| 4 |
Domino's
DPZ
|
+$100M |
| 5 |
SentinelOne
S
|
+$76.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$115M |
| 2 |
Advance Auto Parts
AAP
|
+$93.9M |
| 3 |
Freshpet
FRPT
|
+$93.7M |
| 4 |
Bath & Body Works
BBWI
|
+$92.5M |
| 5 |
Clorox
CLX
|
+$82.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.2% |
| 2 | Healthcare | 22.23% |
| 3 | Industrials | 17.2% |
| 4 | Financials | 15.92% |
| 5 | Consumer Staples | 13.18% |
Similar funds
Champlain Investment Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Champlain Investment Partners held 133 positions worth $16.5B, up 1.4% from $16.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Champlain Investment Partners withdrew a net $583M in Q3 2024, closing 9 positions and reducing 79 holdings. Its most notable exit was Advance Auto Parts, an estimated $93.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Champlain Investment Partners opened a new position in e.l.f. Beauty worth $122M.
- Champlain Investment Partners's largest Q3 2024 buy was e.l.f. Beauty: 1,114,901 shares worth $122M.
- Champlain Investment Partners added most to Repligen in Q3 2024, an estimated $122M increase.
- Champlain Investment Partners's biggest Q3 2024 reduction was Steris, cutting an estimated $115M.
- Champlain Investment Partners fully exited Advance Auto Parts in Q3 2024, selling an estimated $93.9M.
- Champlain Investment Partners's ten largest holdings make up 20% of its $16.5B portfolio in Q3 2024.
- Champlain Investment Partners opened 11 new positions and closed 9 in Q3 2024.
- Champlain Investment Partners's portfolio value rose 1.4% quarter-over-quarter to $16.5B.
Based on Champlain Investment Partners's 13F filing for Q3 2024, filed 12 Nov 2024.